The trace of evidence based medicine in Avicenna's approaches

Journal of Medicinal Plants

Volume 15, Issue 57, Winter 2016, Pages 3-8

Kashani, L.^a, 

Akhondzadeh, S.^b 

 

View additional authors

Retrieving additional authors...

^a  Infertility Ward, Arash Hospital, Tehran University of Medical Sciences, Tehran, Iran
^b  Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran, Iran

View additional affiliations

Retrieving additional affiliations...

View references (21)

Abstract

Many factors underlie the growing popularity of herbal treatments for a variety of chronic conditions. Interestingly, people who use alternative therapies are not necessarily uninformed. If anything, they are more "culturally creative" (i.e., comfortable with cultural changes) and more highly educated. Many people using herbal medicines find the health care alternatives are more congruent with their own values, beliefs and philosophical orientations toward health and life. Similarly, it seems likely that many people feel that herbal medicines are empowering by allowing them to treat themselves without seeing a physician. (This same attitude may be behind the growing popularity of patient-initiated diagnostic scanning procedures such as whole body scans). The danger is that, many people believe that herbal medicines have no toxicity problems or even side effects. In addition, they are not aware of many possible interactions of herbal medicine with concurrent prescribed medications. In this review we focus on Avicenna's evidence based medicine approaches in herbal medicine.

Author keywords

Alternative medicine; Avicenna; Evidence based medicine; Herbal medicine

ISSN: 16840240Source Type: Journal Original language: English

Document Type: Article

Publisher: Institute of Medicinal Plants

View references (21)

References (21)

View in search results format

• Page
• |

• 
  1

  Sepanjnia, K., Modabbernia, A., Ashrafi, M., Modabbernia, M.-J., Akhondzadeh, S.

  Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: Randomized double-blind placebo-controlled trial
  (2012) Neuropsychopharmacology, 37 (9), pp. 2093-2100. Cited 36 times.
  doi: 10.1038/npp.2012.58
  

  • View at Publisher
• 
  2

  Salehi, B., Imani, R., Mohammadi, M.R., Fallah, J., Mohammadi, M., Ghanizadeh, A., Tasviechi, A.A., (...), Akhondzadeh, S.

  Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial
  (2010) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34 (1), pp. 76-80. Cited 39 times.
  doi: 10.1016/j.pnpbp.2009.09.026
  

  • View at Publisher
• 
  3

  Akhondzadeh, S., Fallah, J., Mohammadi, M.-R., Imani, R., Mohammadi, M., Salehi, B., Ghanizadeh, A., (...), Forghani, S.

  Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
  (2010) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34 (1), pp. 32-36. Cited 41 times.
  doi: 10.1016/j.pnpbp.2009.09.012
  

  • View at Publisher
• 
  4

  Akhondzadeh, S., Malek-Hosseini, M., Ghoreishi, A., Raznahan, M., Rezazadeh, S.-A.

  Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study
  (2008) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32 (8), pp. 1879-1883. Cited 33 times.
  doi: 10.1016/j.pnpbp.2008.08.020
  

  • View at Publisher
• 
  5

  Akhondzadeh, S., Gerami, M., Noroozian, M., Karamghadiri, N., Ghoreishi, A., Abbasi, S.-H., Rezazadeh, S.-A.

  A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia
  (2008) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32 (8), pp. 1810-1815. Cited 33 times.
  doi: 10.1016/j.pnpbp.2008.08.001
  

  • View at Publisher
• 
  6

  Akhondzadeh, S., Ahmadi-Abhari, S.A., Assadi, S.M., Shabestari, O.L., Kashani, A.R., Farzanehgan, Z.M.

  Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal
  (2000) Journal of Clinical Pharmacy and Therapeutics, 25 (5), pp. 347-353. Cited 39 times.
  doi: 10.1046/j.1365-2710.2000.00295.x
  

  • View at Publisher
• 
  7

  Naghavi, H.R., Vazirian, M., Shayeganpour, A., Rashidi, H., Khani, M., Akhondzadeh, S.

  Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam
  (2001) Journal of Clinical Pharmacy and Therapeutics, 26 (5), pp. 363-367. Cited 122 times.
  doi: 10.1046/j.1365-2710.2001.00367.x
  

  • View at Publisher
• 
  8

  Kashani, L., Mobaseri, M., Hosseini, S.H., Nikzad, S., Khani, M., Akhondzadeh, S.

  Passionflower in the treatment of opiates withdrawal: A double-blind randomized controlled trial
  (2001) Journal of Clinical Pharmacy and Therapeutics, 26 (5), pp. 369-373. Cited 55 times.
  doi: 10.1046/j.1365-2710.2001.00366.x
  

  • View at Publisher
• 
  9

  Akhondzadeh, S., Kashani, L., Fotouhi, A., Jarvandi, S., Mobaseri, M., Moin, M., Khani, M., (...), Taghizadeh, M.

  Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: A double-blind, randomized trial
  (2003) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27 (1), pp. 123-127. Cited 49 times.
  doi: 10.1016/S0278-5846(02)00342-1
  

  • View at Publisher
• 
  10

  Akhondzadeh, S., Noroozian, M., Mohammadi, M., Ohadinia, S., Jamshidi, A.H., Khani, M.

  Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial
  (2003) Journal of Clinical Pharmacy and Therapeutics, 28 (1), pp. 53-59. Cited 132 times.
  doi: 10.1046/j.1365-2710.2003.00463.x
  

  • View at Publisher
• 
  11

  Akhondzadeh, S., Noroozian, M., Mohammadi, M., Ohadinia, S., Jamshidi, A.H., Khani, M.

  Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial
  (2003) Journal of Neurology Neurosurgery and Psychiatry, 74 (7), pp. 863-866. Cited 96 times.
  doi: 10.1136/jnnp.74.7.863
  

  • View at Publisher
• 
  12

  Akhondzadeh, S., Abbasi, S.H.

  Herbal medicine in the treatment of Alzhelmer's disease
  (2006) American Journal of Alzheimer's Disease and other Dementias, 21 (2), pp. 113-118. Cited 66 times.
  doi: 10.1177/153331750602100211
  

  • View at Publisher
• 
  13

  Farokhnia, M., Shafiee Sabet, M., Iranpour, N., Gougol, A., Yekehtaz, H., Alimardani, R., Farsad, F., (...), Akhondzadeh, S.

  Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: A double-blind randomized clinical trial
  (2014) Human Psychopharmacology, 29 (4), pp. 351-359. Cited 9 times.
  http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1077
  doi: 10.1002/hup.2412
  

  • View at Publisher
• 
  14

  Shahmansouri, N., Farokhnia, M., Abbasi, S.-H., Kassaian, S.E., Noorbala Tafti, A.-A., Gougol, A., Yekehtaz, H., (...), Akhondzadeh, S.

  A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
  (2014) Journal of Affective Disorders, 155 (1), pp. 216-222. Cited 13 times.
  doi: 10.1016/j.jad.2013.11.003
  

  • View at Publisher
• 
  15

  Akhondzadeh, S.

  Herbal medicines in the treatment of psychiatric and neurological disorders
  (2007) Low-Cost Approaches to Promote Physical and Mental Health: Theory, Research, and Practice, pp. 119-138. Cited 15 times.
  http://www.springerlink.com/openurl.asp?genre=book&isbn=978-0-387-36898-6
  ISBN: 0387368981; 978-038736898-6
  doi: 10.1007/0-387-36899-X_6
  

  • View at Publisher
• 
  16

  Akhondzadeh, S., Fallah-Pour, H., Afkham, K., Jamshidi, A.-H., Khalighi-Cigaroudi, F.

  Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]
  (2004) BMC Complementary and Alternative Medicine, 4, art. no. 12, p. 5. Cited 117 times.
  http://www.biomedcentral.com/1472-6882/4/12
  doi: 10.1186/1472-6882-4-12
  

  • View at Publisher
• 
  17

  Akhondzadeh, S., Tahmacebi-Pour, N., Noorbala, A.-A., Amini, H., Fallah-Pour, H., Jamshidi, A.-H., Khani, M.

  Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomized and placebo-controlled trial
  (2005) Phytotherapy Research, 19 (2), pp. 148-151. Cited 116 times.
  doi: 10.1002/ptr.1647
  

  • View at Publisher
• 
  18

  Akhondzadeh Basti, A., Moshiri, E., Noorbala, A.-A., Jamshidi, A.-H., Abbasi, S.H., Akhondzadeh, S.

  Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial
  (2007) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31 (2), pp. 439-442. Cited 87 times.
  doi: 10.1016/j.pnpbp.2006.11.010
  

  • View at Publisher
• 
  19

  Akhondzadeh, S., Sabet, M.S., Harirchian, M.H., Togha, M., Cheraghmakani, H., Razeghi, S., Hejazi, S.S., (...), Moradi, A.

  Saffron in the treatment of patients with mild to moderate Alzheimer's disease: A 16-week, randomized and placebo-controlled trial
  (2010) Journal of Clinical Pharmacy and Therapeutics, 35 (5), pp. 581-588. Cited 55 times.
  doi: 10.1111/j.1365-2710.2009.01133.x
  

  • View at Publisher
• 
  20

  Akhondzadeh, S., Shafiee Sabet, M., Harirchian, M.H., Togha, M., Cheraghmakani, H., Razeghi, S., Hejazi, S.S., (...), Vossoughi, A.

  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease
  (2010) Psychopharmacology, 207 (4), pp. 637-643. Cited 62 times.
  doi: 10.1007/s00213-009-1706-1
  

  • View at Publisher
• 
  21

  Akhondzadeh, S.

  Hippocampal synaptic plasticity and cognition
  (1999) Journal of Clinical Pharmacy and Therapeutics, 24 (4), pp. 241-248. Cited 38 times.
  doi: 10.1046/j.1365-2710.1999.00231.x
  

  • View at Publisher

  Akhondzadeh, S.; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Street, Iran; email:s.akhond@neda.net
© Copyright 2016 Elsevier B.V., All rights reserved.